- Home
- YMAT vs IBIO Comparison
YMAT vs IBIO Comparison
Compare YMAT & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.56
HOLD
Current Price
$2.28
Company Overview
Basic Information| Metric | YMAT | IBIO |
|---|---|---|
| Founded | 1970 | 2008 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4M | 16.4M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | YMAT | IBIO |
|---|---|---|
| Price | $0.56 | $2.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 105.3K | ★ 3.1M |
| Earning Date | 02-09-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $20,054,081.00 | $500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.11 |
| P/E Ratio | $15.83 | ★ N/A |
| Revenue Growth | 11.79 | ★ 185.71 |
| 52 Week Low | $0.40 | $0.56 |
| 52 Week High | $6.45 | $6.89 |
Technical Indicators
Market Signals| Indicator | YMAT | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 55.36 |
| Support Level | N/A | $2.39 |
| Resistance Level | N/A | $2.89 |
| Average True Range (ATR) | 0.00 | 0.28 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 47.48 |
Price Performance
Historical Comparison YMAT
IBIO
About YMAT J-Star Holding Co. Ltd. Ordinary Shares
J Star Holding Co Ltd is engaged in the research, development and manufacturing of carbon fiber for a wide variety of products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.